http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014371101-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2014-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e193217d22ced428d3fa62b82bf76ce6
publicationDate 2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014371101-A1
titleOfInvention PARP Substrates and Biomarkers
abstract PARylated proteins are enriched by treating cell lysates comprising PARylated proteins and DNA/RNA with an endonuclease that cleaves the DNA/RNA but not the PAR; and separating the PARylated proteins from the cleaved DNA/RNA. PARylation sites are labeled by eluting PARylated proteins from a PAR-affinity substrate with a nucleophilic amine exchange reactant, wherein the reactant labels PARylation sites of the proteins. Specific binding agents are identified by screening compounds for specific binding to a PARylated protein disclosed herein; and identifying one of the compounds as a specific binder of the protein. Antibodies which specifically bind PARylation sites are also disclosed.
priorityDate 2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4504586-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128580330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18645657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128380569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10333641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228030536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44579957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127998224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226592408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226592923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128833854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9796068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129396299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128912572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6278

Total number of triples: 43.